Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007
NCT01470924 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76
Last updated 2011-11-11
Summary
A minority of patients with adult acute lymphoblastic leukemia (ALL) relapse are rescued. The aim of this population-based study was to assess the results of reinduction treatment and allogeneic stem cell transplantation (SCT) in second complete remission (CR) in Sweden 2003-2007.
Conditions
Sponsors & Collaborators
-
Region Örebro County
lead OTHER
Principal Investigators
-
Piotr J Kozlowski, MD · Region Örebro County
Eligibility
- Min Age
- 18 Years
- Max Age
- 66 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-01-31
- Completion
- 2011-06-30
Countries
- Sweden
Study Locations
More Related Trials
-
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
NCT03911128 ·Status: RECRUITING
-
Evaluation of Long-term Health Status and Quality of Life in Adult Survivors With Philadelphia-negative Acute Lymphoblastic Leukemia/Lymphoma Treated With an Intensive Pediatric or Pediatric-inspired Protocol
NCT04677231 ·Status: UNKNOWN
-
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024 ·Status: RECRUITING
-
Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
NCT00002514 ·Status: COMPLETED ·Phase: PHASE3
-
Disease Stabilization in AML by Treatment With ATRA, Valproic Acid and Low-dose Cytarabine
NCT00995332 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden.
NCT01950286 ·Status: COMPLETED
-
Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)
NCT01037764 ·Status: TERMINATED ·Phase: PHASE2
-
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
NCT00430118 ·Status: COMPLETED ·Phase: PHASE3
-
Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
NCT00186381 ·Status: COMPLETED ·Phase: PHASE2
-
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
NCT03204916 ·Status: COMPLETED
-
A Study of HY004 Treatment in Adult Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r B-ALL)
NCT06009107 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment
NCT02881086 ·Status: COMPLETED ·Phase: PHASE3
-
ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN
NCT04639024 ·Status: TERMINATED ·Phase: PHASE2
-
Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia
NCT02842112 ·Status: COMPLETED
-
Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia
NCT00337519 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia
NCT01814488 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of an Adult Acute Lymphoblastic Leukemia Chemotherapy for Adult Lymphoblastic Lymphoma
NCT00195871 ·Status: UNKNOWN ·Phase: PHASE2
-
Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine
NCT01392079 ·Status: COMPLETED ·Phase: PHASE2
-
Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients
NCT02433483 ·Status: TERMINATED ·Phase: PHASE2
-
Treatment of Adult ALL With an MRD-directed Programme.
NCT00358072 ·Status: COMPLETED ·Phase: PHASE2
-
Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients
NCT02042690 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
NCT00002499 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Differentiation Induction in Acute Myelogenous Leukemia
NCT00175812 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia
NCT03339700 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia
NCT00199095 ·Status: COMPLETED ·Phase: PHASE4